Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

IMMUNOGLOBULIN E - ANVISA Registration 10033121027

Access comprehensive regulatory information for IMMUNOGLOBULIN E in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10033121027 and manufactured by BECKMAN COULTER, INC.. The registration is held by BECKMAN COULTER DO BRASIL COMÉRCIO E IMPORTAÇÃO DE PRODUTOS DE LABORATÓRIO LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including PHADIA AB, SHENZHEN DYMIND BIOTECHNOLOGY CO., LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10033121027
Registration Details
ANVISA Registration Number: 10033121027
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Total Immunoglobulin E (IgE)
Risk Class II

Registration Details

10033121027

25351113284202268

42160812000144

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Jul 07, 2022

VIGENTE

09/18/2025 19:00:01